Epitomee Medical (Israel) Investor Sentiment

EPIT Stock   902.60  3.00  0.33%   
About 62% of Epitomee Medical's investor base is looking to short. The analysis of current outlook of investing in Epitomee Medical suggests that many traders are alarmed regarding Epitomee Medical's prospects. The current market sentiment, together with Epitomee Medical's historical and current headlines, can help investors time the market. In addition, many technical investors use Epitomee Medical stock news signals to limit their universe of possible portfolio assets.
  
over a month ago at news.google.com         
We Think Epitomee Medical Might Have The DNA Of A Multi-Bagger - Simply Wall St
Google News at Macroaxis
over three months ago at news.google.com         
Achieve Investment Group and Epitome Development Obtain Entitlements on 500m Mixed-Use Project in Au...
Google News at Macroaxis
over three months ago at news.google.com         
Statutory Profit Doesnt Reflect How Good Epitomee Medicals Earnings Are - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
ELOS - ELOS Latest Stock News Market Updates - StockTitan
Google News at Macroaxis
over six months ago at news.google.com         
Nestle-partnered weight loss capsule succeeds in pivotal trial - MSN
Google News at Macroaxis
over six months ago at news.google.com         
We Think Epitomee Medical Can Afford To Drive Business Growth - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
We Think Epitomee Medical Can Afford To Drive Business Growth - Simply Wall St
Google News at Macroaxis
over a year ago at news.google.com         
Epitomee files FDA application for swallowable weight loss capsule - BioWorld Online
Google News at Macroaxis
over a year ago at news.google.com         
Epitomee announces the filing of a novel Weight Loss Capsule for FDA clearance - PR Newswire
Google News at Macroaxis
over a year ago at news.google.com         
Epitomee Submits Revolutionary Weight Loss Capsule for FDA Clearance, Targets BMI 25-40 - BNN Breaki...
Google News at Macroaxis
over a year ago at news.google.com         
Epitomee Announces Successful Completion of Pivotal Clinical Trial for Innovative Weight Loss Capsul...
Google News at Macroaxis
over a year ago at news.google.com         
Weight loss pill maker Epitomees stock sinks 70 percent after Nestl cancels agreement - CTech
Google News at Macroaxis
over a year ago at news.google.com         
Epitomee slumps as Nestle nixes marketing weight loss pill - Globes
Google News at Macroaxis
over a year ago at news.google.com         
Semaglutide delivers 20 percent reduction in major adverse ... - EurekAlert
Google News at Macroaxis
over a year ago at news.google.com         
No. 5 Marquette opens season at home against Northern Illinois - Oil City Derrick
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Epitomee Medical that are available to investors today. That information is available publicly through Epitomee media outlets and privately through word of mouth or via Epitomee internal channels. However, regardless of the origin, that massive amount of Epitomee data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Epitomee Medical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Epitomee Medical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Epitomee Medical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Epitomee Medical alpha.

Epitomee Medical Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Epitomee Stock analysis

When running Epitomee Medical's price analysis, check to measure Epitomee Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Epitomee Medical is operating at the current time. Most of Epitomee Medical's value examination focuses on studying past and present price action to predict the probability of Epitomee Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Epitomee Medical's price. Additionally, you may evaluate how the addition of Epitomee Medical to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities